Retraction

Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11

Citations (7)

7
Total Citations
3
Post-Retraction
(42.9%)
2
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
0 After 2+ years
292 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
The effect of TFAP2A/ANXA8 axis on ferroptosis of cervical squamous cell carcinoma (CESC) in vitro
Yuehua Sheng, Huiqing Ding, Jiaqing Zhou et al. (7 authors)
Cytotechnology
Published: Apr 2024
3 citations
292 days after retraction
HDAC11: A novel target for improved cancer therapy
Yan Liu, Xuechao Tong, Weina Hu et al. (4 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Sep 2023
11 citations
75 days after retraction
Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma
Ming-He Zhang, Yufeng Yuan, Lijuan Liu et al. (9 authors)
World Journal of Gastroenterology Open Access
Published: Aug 2023
10 citations
58 days after retraction
Retracted: Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11
Disease Markers
Disease Markers Open Access
Published: Jun 2023
Same day as retraction
miR-135a inhibits the proliferation of HBV-infected hepatocellular carcinoma cells by targeting HOXA10
Jianjun Lin, Xiang Lian, Shihang Xue et al. (7 authors)
Translational Cancer Research Open Access
Published: Jan 2023
5 citations
171 days before retraction
HDAC11, an emerging therapeutic target for metabolic disorders
Huizhen Chen, Chunguang Xie, Qiu Chen et al. (4 authors)
Frontiers in Endocrinology Open Access
Published: Oct 2022
37 citations
244 days before retraction
Quick Stats
Total Citations: 11
Years Since Retraction: 2.4 years
Open Access: Yes
Last Checked: Jul 24, 2025